Syner-KINASE® (urokinase) is licensed in the UK for the treatment of occluded catheters and systemic thromboembolic occlusive disease (diseases caused by blood clots).
Syner-KINASE® is free of human albumin and is available in vials of 10,000 IU, 25,000 IU and 100,000 IU.
The catheter lock dose is up to 25,000 IU per lumen and can be given by push-lock.
Syner-KINASE® (urokinase) is the only urokinase free of human albumin
|Syner-KINASE® (urokinase) Summary of Product Characteristics (SPC)||462.05 KB|
|Syner-KINASE® (urokinase) Patient Information Leaflet (PIL)||42.3 KB|